Cabaletta Bio(CABA)
$1.450.00 (0.00%)
CABA
Cabaletta Bio financials statements
$1.45
At close:0.00 (0.00%)
Want to see CABA full AI Analyst Report?
Cabaletta Bio (CABA) Ratios
1,670 Followers
Cabaletta Bio Ratios
CABA's free cash flow for Q3 2026 was $-42.89M. For the 2026 fiscal year, CABA's free cash flow was decreased by $-142.00K and operating cash flow was $-42.74M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.77 | 6.15 | 15.29 | 11.47 | 14.86 |
| Quick Ratio | 2.77 | 6.15 | 15.29 | 11.47 | 14.86 |
| Cash Ratio | 1.65 | 6.05 | 12.08 | 8.60 | 14.58 |
| Solvency Ratio | -3.13 | -3.49 | -3.80 | -3.96 | -5.44 |
| Operating Cash Flow Ratio | -2.61 | -3.26 | -3.35 | -4.89 | -4.07 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 85.84M | $ 133.96M | $ 227.04M | $ 96.39M | $ 116.16M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.08 | 0.02 | 0.04 | 0.00 |
| Debt-to-Equity Ratio | 0.24 | 0.10 | 0.02 | 0.05 | 0.00 |
| Debt-to-Capital Ratio | 0.19 | 0.09 | 0.02 | 0.05 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.47 | 1.21 | 1.07 | 1.12 | 1.07 |
| Debt Service Coverage Ratio | -81.94 | -151.61 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | -85.95 | -167.30 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.28 | 0.33 | 0.12 | 0.18 | 0.00 |
| Net Debt to EBITDA | 0.34 | 1.31 | 2.84 | 1.55 | 2.68 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 97.45% | 92.59% | 90.64% | 97.85% | 99.95% |
| Return on Assets (ROA) | -101.68% | -62.61% | -26.68% | -45.29% | -36.64% |
| Return on Equity (ROE) | -149.80% | -76.06% | -28.65% | -50.68% | -39.24% |
| Return on Capital Employed (ROCE) | -149.87% | -79.22% | -31.42% | -50.37% | -39.26% |
| Return on Invested Capital (ROIC) | -123.78% | -72.81% | -30.95% | -49.37% | -39.26% |
| Return on Tangible Assets | -101.68% | -62.61% | -26.68% | -45.29% | -36.64% |
| Earnings Yield | -74.95% | -103.06% | -7.28% | -19.52% | -47.45% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.31 | 1.50 | 0.31 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -1163.85 | -244.03 | -1161.73 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 1163.85 | 244.03 | 1161.73 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.28 | -1.78 | -1.31 | -1.58 | -1.33 |
| Free Cash Flow Per Share | -1.29 | -1.83 | -1.32 | -1.66 | -1.37 |
| Dividend Paid and CapEx Coverage Ratio | -106.66 | -39.90 | -77.95 | -18.91 | -29.25 |
| Capital Expenditure Coverage Ratio | -106.66 | -39.90 | -77.95 | -18.91 | -29.25 |
| Operating Cash Flow Coverage Ratio | -4.84 | -5.66 | -10.67 | -9.03 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -59.08% | -80.44% | -5.84% | -17.99% | -36.16% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.34 | -0.97 | -13.73 | -5.12 | -2.11 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.00 | 0.74 | 3.94 | 2.60 | 0.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.69 | -1.24 | -17.14 | -5.56 | -2.77 |
| Price-to-Operating Cash Flow Ratio | -1.71 | -1.27 | -17.36 | -5.85 | -2.86 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -0.02 | 1.55 | -9.22 | -0.08 |
| Enterprise Value Multiple | -1.02 | 0.32 | -11.19 | -3.96 | 0.54 |
| Enterprise Value | 168.07M | -35.94M | 741.25M | 194.95M | -24.68M |
| EV to EBITDA | -1.02 | 0.32 | -11.19 | -3.96 | 0.54 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -1.27 | 0.40 | -13.67 | -3.99 | 0.70 |
| EV to Operating Cash Flow | -1.28 | 0.41 | -13.84 | -4.20 | 0.72 |
| Tangible Book Value Per Share | 1.10 | 3.08 | 5.77 | 3.56 | 4.58 |
| Shareholders’ Equity Per Share | 1.10 | 3.08 | 5.77 | 3.56 | 4.58 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.64 | -2.34 | -1.65 | -1.81 | -1.80 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.01 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.78 | 0.76 | 0.79 | 0.88 | 0.74 |
Currency in USD
